Managing vitreoretinal complications in uveal melanoma: Surgical treatment and practical considerations

Rodrigo Anguita; Hung-Da Chou; Vishal R Raval; Vidhi Bajpai; Lorenzo Ferro Desideri; Enrico Bernardi; Rumana N Hussain; Min Kim; Adrian T Fung; Basil K Williams; Maura Di Nicola; Mandeep S Sagoo; Lyndon da Cruz; Bertil Damato; Jens Folke Kiilgaard

doi:10.1080/08820538.2024.2381774

Managing vitreoretinal complications in uveal melanoma: Surgical treatment and practical considerations

Rodrigo Anguita, Hung-Da Chou^*, Vishal R Raval, Vidhi Bajpai, Lorenzo Ferro Desideri, Enrico Bernardi, Rumana N Hussain, Min Kim, Adrian T Fung, Basil K Williams, Maura Di Nicola, Mandeep S Sagoo, Lyndon da Cruz, Bertil Damato, Jens Folke Kiilgaard

^*Corresponding author af dette arbejde

Afdeling for Øjensygdomme

Abstract

BACKGROUND: In the past few decades, the primary management for uveal melanoma has evolved from enucleation to eye-preserving treatments. However, despite achieving a high rate of local tumour control, complications following eye-preserving treatments still occur and are partly responsible for functional loss and secondary enucleation.

METHODS: A literature review by a broad international panel.

RESULTS: We summarised the current literature on utilizing vitreoretinal (VR) surgery for managing the complications of uveal melanoma. We also provided insights from the authors' personal experience and practical recommendations for clinical care.

CONCLUSIONS: With the advancement of VR instruments and surgical techniques and the combination of VR and ocular oncology knowledge ("Onco-VR"), it is now possible to manage or even prevent complications such as vitreous haemorrhage, retinal detachment, and toxic tumour syndrome.

Originalsprog	Engelsk
Tidsskrift	Seminars in ophthalmology
Sider (fra-til)	1-10
Antal sider	10
ISSN	0882-0538
DOI	https://doi.org/10.1080/08820538.2024.2381774
Status	E-pub ahead of print - 28 aug. 2024

Adgang til dokumentet

10.1080/08820538.2024.2381774

Andre filer og links

Link to publication in Scopus

Citationsformater

Anguita, R., Chou, H.-D., Raval, V. R., Bajpai, V., Ferro Desideri, L., Bernardi, E., Hussain, R. N., Kim, M., Fung, A. T., Williams, B. K., Di Nicola, M., Sagoo, M. S., da Cruz, L., Damato, B., & Kiilgaard, J. F. (2024). Managing vitreoretinal complications in uveal melanoma: Surgical treatment and practical considerations. Seminars in ophthalmology, 1-10. Advance online publication. https://doi.org/10.1080/08820538.2024.2381774

Anguita, R, Chou, H-D, Raval, VR, Bajpai, V, Ferro Desideri, L, Bernardi, E, Hussain, RN, Kim, M, Fung, AT, Williams, BK, Di Nicola, M, Sagoo, MS, da Cruz, L, Damato, B & Kiilgaard, JF 2024, 'Managing vitreoretinal complications in uveal melanoma: Surgical treatment and practical considerations', Seminars in ophthalmology, s. 1-10. https://doi.org/10.1080/08820538.2024.2381774

@article{85029a20d99649e7a874481f87e261bc,

title = "Managing vitreoretinal complications in uveal melanoma: Surgical treatment and practical considerations",

abstract = "BACKGROUND: In the past few decades, the primary management for uveal melanoma has evolved from enucleation to eye-preserving treatments. However, despite achieving a high rate of local tumour control, complications following eye-preserving treatments still occur and are partly responsible for functional loss and secondary enucleation.METHODS: A literature review by a broad international panel.RESULTS: We summarised the current literature on utilizing vitreoretinal (VR) surgery for managing the complications of uveal melanoma. We also provided insights from the authors' personal experience and practical recommendations for clinical care.CONCLUSIONS: With the advancement of VR instruments and surgical techniques and the combination of VR and ocular oncology knowledge ({"}Onco-VR{"}), it is now possible to manage or even prevent complications such as vitreous haemorrhage, retinal detachment, and toxic tumour syndrome.",

author = "Rodrigo Anguita and Hung-Da Chou and Raval, {Vishal R} and Vidhi Bajpai and {Ferro Desideri}, Lorenzo and Enrico Bernardi and Hussain, {Rumana N} and Min Kim and Fung, {Adrian T} and Williams, {Basil K} and {Di Nicola}, Maura and Sagoo, {Mandeep S} and {da Cruz}, Lyndon and Bertil Damato and Kiilgaard, {Jens Folke}",

year = "2024",

month = aug,

day = "28",

doi = "10.1080/08820538.2024.2381774",

language = "English",

pages = "1--10",

journal = "Seminars in ophthalmology",

issn = "0882-0538",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Managing vitreoretinal complications in uveal melanoma

T2 - Surgical treatment and practical considerations

AU - Anguita, Rodrigo

AU - Chou, Hung-Da

AU - Raval, Vishal R

AU - Bajpai, Vidhi

AU - Ferro Desideri, Lorenzo

AU - Bernardi, Enrico

AU - Hussain, Rumana N

AU - Kim, Min

AU - Fung, Adrian T

AU - Williams, Basil K

AU - Di Nicola, Maura

AU - Sagoo, Mandeep S

AU - da Cruz, Lyndon

AU - Damato, Bertil

AU - Kiilgaard, Jens Folke

PY - 2024/8/28

Y1 - 2024/8/28

N2 - BACKGROUND: In the past few decades, the primary management for uveal melanoma has evolved from enucleation to eye-preserving treatments. However, despite achieving a high rate of local tumour control, complications following eye-preserving treatments still occur and are partly responsible for functional loss and secondary enucleation.METHODS: A literature review by a broad international panel.RESULTS: We summarised the current literature on utilizing vitreoretinal (VR) surgery for managing the complications of uveal melanoma. We also provided insights from the authors' personal experience and practical recommendations for clinical care.CONCLUSIONS: With the advancement of VR instruments and surgical techniques and the combination of VR and ocular oncology knowledge ("Onco-VR"), it is now possible to manage or even prevent complications such as vitreous haemorrhage, retinal detachment, and toxic tumour syndrome.

AB - BACKGROUND: In the past few decades, the primary management for uveal melanoma has evolved from enucleation to eye-preserving treatments. However, despite achieving a high rate of local tumour control, complications following eye-preserving treatments still occur and are partly responsible for functional loss and secondary enucleation.METHODS: A literature review by a broad international panel.RESULTS: We summarised the current literature on utilizing vitreoretinal (VR) surgery for managing the complications of uveal melanoma. We also provided insights from the authors' personal experience and practical recommendations for clinical care.CONCLUSIONS: With the advancement of VR instruments and surgical techniques and the combination of VR and ocular oncology knowledge ("Onco-VR"), it is now possible to manage or even prevent complications such as vitreous haemorrhage, retinal detachment, and toxic tumour syndrome.

UR - http://www.scopus.com/inward/record.url?scp=85202721916&partnerID=8YFLogxK

U2 - 10.1080/08820538.2024.2381774

DO - 10.1080/08820538.2024.2381774

M3 - Review

C2 - 39194361

SN - 0882-0538

SP - 1

EP - 10

JO - Seminars in ophthalmology

JF - Seminars in ophthalmology

ER -

Managing vitreoretinal complications in uveal melanoma: Surgical treatment and practical considerations

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater